Life Science Compliance Update



This Isn’t Walmart: The Supreme Court Narrows Forum-Shopping Options

Written by , Posted in Tort reform

Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update

In a decision of great import to pharmaceutical and device companies, the Supreme Court ruled in favor of Bristol-Myers Squibb in a jurisdictional argument at the nation’s Highest Court. This article outlines the background, the case decision, and the decision’s ramifications to companies.


Topic tags:

Menu Title